Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy Following Chemoradiation in High-Risk Early-Stage Cervical Cancer
NCT00980954Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Sep 2009
- Primary completion
- Dec 2023
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 4
01
Overview
A Phase 3 trial of carboplatin, Paclitaxel Micelles for Injection in Cervical Cancer (CC), sponsored by NRG Oncology. Started Sep 2009; status: completed.
02
Drugs
carboplatinPaclitaxel Micelles for Injection
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00980954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00980954.